ArticleAdvances in experimental medicine and biology2022
Bioinformatics for the Origin and Evolution of Viruses.
Article in Advances in experimental medicine and biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The ongoing pandemic of coronavirus disease 2019 (COVID19) caused by infection with human SARS-CoV-2 is a global threat to the human population. World effort has arisen toward the characterization of the origin and evolutionary features of this devastating virus. The development of high-throughput sequencing platforms has facilitated the surveillance of viral sequence diversity in both human and animal populations. Bioinformatics pipelines are readily available for ongoing virus tracking on a global level. In this chapter, we summarize the bioinformatics tools in the origin tracing and evolutionary analyses of viruses with a highlight in their application in SARS-CoV-2, which will facilitate the prevention of the pandemic as well as custom-designed antiviral strategies.
Indexed as
Identifiers
35594020What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.